Mutated Abl kinase domains

Details for Australian Patent Application No. 2002347054 (hide)

Owner NOVARTIS AG UNIVERSITE VICTOR SEGALEN BORDEAUX 2 TECHNISCHE UNIVERSITAT MUNCHEN OREGON HEALTH AND SCIENCE UNIVERSITY UNIVERSITY OF HEIDELBERG CHRU DE LILLE MEDVET SCIENCE PTY. LTD.

International Classifications

Event Publications

13 March 2003 Complete Application Filed

Priority application(s): 60/327,389 05.10.01 US; 60/347,351 11.01.02 US; 60/328,740 12.10.01 US

3 July 2003 Application Open to Public Inspection

Published as AU-A-2002347054

29 March 2007 Change of Name(s) of Applicant(s), Section 104

Medvet Science Pty. Ltd.; Universite Victor Segalen Bordeaux 2; Technische Universitat Munchen; Oregon Health & Science University; University of Heidelberg; Chru De Lille; Novartis AG The name of the applicant has been changed to Medvet Science Pty. Ltd.; Universite Victor Segalen Bordeaux 2; Technische Universitat Munchen; Oregon Health & Science University; University of Heidelberg; Chru De Lille

26 April 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.